These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2243063)

  • 1. Inhibition of psoriatic cell proliferation in in vitro skin models by amiprilose hydrochloride.
    Chapman ML; Dimitrijevich SD; Hevelone JC; Goetz D; Cohen J; Wise GE; Gracy RW
    In Vitro Cell Dev Biol; 1990 Oct; 26(10):991-6. PubMed ID: 2243063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amiprilose hydrochloride on the components of human skin equivalents.
    Hevelone JC; Dimitrijevich SD; Gracy RW
    In Vitro Cell Dev Biol; 1991 May; 27A(5):387-96. PubMed ID: 2071542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased cell proliferation and PGE2 production by fibroblasts treated with a modified hexose sugar, amiprilose hydrochloride.
    Brinckerhoff CE
    Agents Actions; 1990 Jun; 30(3-4):322-8. PubMed ID: 2386107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast-keratinocyte interactions in psoriasis: failure of psoriatic fibroblasts to stimulate keratinocyte proliferation in vitro.
    Priestley GC; Lord R
    Br J Dermatol; 1990 Oct; 123(4):467-72. PubMed ID: 2095178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiprilose hydrochloride inhibits porcine aortic smooth muscle cell proliferation in vitro.
    Siegel CO; Churchill DA; Vu L; Guyton JR; Minor ST; Raizner AE
    Artery; 1994; 21(2):114-23. PubMed ID: 7695482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3.
    MacLaughlin JA; Gange W; Taylor D; Smith E; Holick MF
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5409-12. PubMed ID: 2991921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of IFN-gamma on healthy and psoriatic keratinocytes in a skin equivalent model is influenced by the source of the keratinocytes and by their interactions with fibroblasts.
    Fransson J; Shen Q; Scheynius A; Hammar H
    Arch Dermatol Res; 1996 Dec; 289(1):14-20. PubMed ID: 9017130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental models for psoriasis.
    Krueger GG; Jorgensen CM
    J Invest Dermatol; 1990 Nov; 95(5 Suppl):56S-58S. PubMed ID: 16788635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of cultured keratinocytes and fibroblasts from human psoriatic and normal skin in immunodeficient mice.
    Sugai J; Katakai Y; Iizuka M; Kawakubo Y; Ozawa A; Ohkido M; Ueyama Y; Tamaoki N; Inokochi S; Shimamura K
    J Dermatol Sci; 1998 Jul; 17(3):190-7. PubMed ID: 9697047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor-alpha does not influence proliferation and differentiation of healthy and psoriatic keratinocytes in a skin-equivalent model.
    Fransson J
    Acta Derm Venereol; 2000; 80(6):416-20. PubMed ID: 11243633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory effects of a synthetic monosaccharide.
    Chang DM
    Immunopharmacol Immunotoxicol; 1995 Aug; 17(3):437-50. PubMed ID: 8576539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation and interferon-gamma receptor expression in psoriatic and healthy keratinocytes are influenced by interactions between keratinocytes and fibroblasts in a skin equivalent model.
    Fransson J; Emilson A; Scheynius A; Hammar H
    Arch Dermatol Res; 1995; 287(6):517-23. PubMed ID: 7487135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of epidermal cell thymocyte-activating factor (ETAF) from cultured human keratinocytes from normal and uninvolved psoriatic skin.
    Kragballe K; Marcelo CL; Voorhees JJ; Sauder DN
    J Invest Dermatol; 1987 Jan; 88(1):8-10. PubMed ID: 3491857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal and psoriatic keratinocytes.
    Hashimoto K; Matsumoto K; Higashiyama M; Nishida Y; Yoshikawa K
    Br J Dermatol; 1990 Jul; 123(1):93-8. PubMed ID: 2390499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial hyperproliferation and incomplete terminal differentiation of cultured human keratinocytes from lesional and uninvolved psoriatic skin.
    Detmar M; Mayer-da-Silva A; Stadler R; Orfanos CE
    Acta Derm Venereol; 1990; 70(4):295-9. PubMed ID: 1977252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro.
    Leigh IM; Navsaria H; Purkis PE; McKay IA; Bowden PE; Riddle PN
    Br J Dermatol; 1995 Oct; 133(4):501-11. PubMed ID: 7577575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions.
    Nickoloff BJ; Mitra RS; Elder JT; Fisher GJ; Voorhees JJ
    Br J Dermatol; 1989 Aug; 121(2):161-74. PubMed ID: 2476168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin.
    Abe J; Kondo S; Nishii Y; Kuroki T
    J Clin Endocrinol Metab; 1989 Apr; 68(4):851-4. PubMed ID: 2921314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial cultivation of epidermal keratinocytes from psoriatic plaques.
    Liu SC; Parsons CS
    J Invest Dermatol; 1983 Jul; 81(1):54-61. PubMed ID: 6863980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a modified hexose sugar, amiprilose hydrochloride, in experimental models of synovitis.
    Kieval RI; Young CT; Prohazka D; Brinckerhoff CE; Trentham DE
    J Rheumatol; 1989 Jan; 16(1):67-74. PubMed ID: 2785600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.